Core Insights - The article highlights the advancements in artificial intelligence and brain science being developed in Hangzhou, showcasing significant innovations in brain-machine interface technology and advanced microscopy systems [2][4]. Group 1: Innovations in Technology - Zhejiang Hehu Technology has developed a lightweight, head-mounted smart microscope that captures real-time brain activity in small animals, breaking the long-standing foreign monopoly in high-end microscopy [5]. - The technology features three core products: scanning light field microscopy, live mesoscopic microscopy, and a large-field head-mounted micro-microscope, which significantly enhance imaging capabilities while minimizing light toxicity [5]. - The company won a gold medal at the National Postdoctoral Innovation and Entrepreneurship Competition, emphasizing its potential applications beyond neuroscience, including drug development [5][6]. Group 2: Brain-Machine Interface Development - West Lake Lingxi Technology has created an implantable brain-machine interface chip that translates brain waves of individuals who have lost their ability to speak into Chinese sentences, effectively allowing silent thoughts to be expressed [4][8]. - The technology has filled a gap in the international market for decoding Chinese brain waves, showcasing the potential of artificial intelligence in treating brain diseases and enhancing communication [7][8]. - The company has established a complete technical system from high-throughput neural signal acquisition chips to intelligent decoding algorithms, indicating a robust foundation for future growth and commercialization [8].

Core Insights - The 17th China Bio-Industry Conference opened in Wuhan, marking it as the largest and most influential professional event in China's bio-industry sector [1] - The conference showcased significant innovations, including the world's first plant-derived recombinant human serum albumin injection, Aofumin®, developed by Wuhan Heyuan Biotechnology Co., Ltd. [2] - The conference highlighted various groundbreaking products, including a visual intervention robot system and an implantable brain-computer interface chip, attracting considerable attention from attendees [5] Industry Developments - The conference featured the world's first clinical research candidate for oncolytic virus therapy, OH2 injection, developed by Wuhan Binhui Biotechnology Co., Ltd. [5] - The "China Bio-Economy Development Report 2025" was released, indicating that China's bio-economy industry remains the largest globally and is experiencing continuous growth [10] - Wuhan has established itself as a permanent host for the China Bio-Industry Conference since 2018, developing a comprehensive bio-pharmaceutical industry cluster with a scale exceeding 550 billion yuan [10]